NF-ĸB axis in diabetic neuropathy, cardiomyopathy and nephropathy: A roadmap from molecular intervention to therapeutic strategies
Aryan Rezaee,Parham Rahmanian,Amirreza Nemati,Farima Sohrabifard,Fatemeh Karimi,Ali Elahinia,Ali Ranjbarpazuki,Rozhin Lashkarbolouki,Sadaf Dezfulian,Mohammad Arad Zandieh,Shokooh Salimimoghadam,Noushin Nabavi,Mohsen Rashidi,Afshin Taheriazam,Mehrdad Hashemi,Kiavash Hushmandi
DOI: https://doi.org/10.1016/j.heliyon.2024.e29871
IF: 3.776
2024-04-18
Heliyon
Abstract:Diabetes mellitus (DM) is a metabolic illness defined by elevated blood glucose levels, mediating various tissue alterations, including the dysfunction of vital organs. Diabetes mellitus (DM) can lead to many consequences that specifically affect the brain, heart, and kidneys. These issues are known as neuropathy, cardiomyopathy, and nephropathy, respectively. Inflammation is acknowledged as a pivotal biological mechanism that contributes to the development of various diabetes consequences. NF-κB modulates inflammation and the immune system at the cellular level. Its abnormal regulation has been identified in several clinical situations, including cancer, inflammatory bowel illnesses, cardiovascular diseases, and Diabetes Mellitus (DM). The purpose of this review is to evaluate the potential impact of NF-κB on complications associated with DM. Enhanced NF-κB activity promotes inflammation, resulting in cellular harm and compromised organ performance. Phytochemicals, which are therapeutic molecules, can potentially decline the NF-κB level, therefore alleviating inflammation and the progression of problems correlated with DM. More importantly, the regulation of NF-κB can be influenced by various factors, such as TLR4 in DM. Highlighting these factors can facilitate the development of novel therapies in the future.